RS49772B - Farmaceutske kompozicije - Google Patents

Farmaceutske kompozicije

Info

Publication number
RS49772B
RS49772B YUP-477/99A YU47799A RS49772B RS 49772 B RS49772 B RS 49772B YU 47799 A YU47799 A YU 47799A RS 49772 B RS49772 B RS 49772B
Authority
RS
Serbia
Prior art keywords
pharmaceutical compositions
less
composition
lamivudine
paraben
Prior art date
Application number
YUP-477/99A
Other languages
English (en)
Inventor
Ngoc-Anh Thi Nguyen
Warren M. Casey
Original Assignee
Glaxo Group Limited,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706295.4A external-priority patent/GB9706295D0/en
Application filed by Glaxo Group Limited, filed Critical Glaxo Group Limited,
Publication of YU47799A publication Critical patent/YU47799A/sh
Publication of RS49772B publication Critical patent/RS49772B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Farmaceutska kompozicija, naznačena time, što sadrži manje od 3% etanola i manje od 0,005% etilendiamintetrasirćetne kiseline, a sadrži lamivudin ili njegov farmaceutski prihvatljiv derivat i zaštitni sistem koji sadrži parabene, a pomenuta kompozicija ima pH veći od 5,5. Prijava sadrži još 13 zahteva.
YUP-477/99A 1997-03-24 1998-03-20 Farmaceutske kompozicije RS49772B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4235397P 1997-03-24 1997-03-24
GBGB9706295.4A GB9706295D0 (en) 1997-03-26 1997-03-26 Lamivudine formulation

Publications (2)

Publication Number Publication Date
YU47799A YU47799A (sh) 2002-06-19
RS49772B true RS49772B (sr) 2008-06-05

Family

ID=26311267

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-477/99A RS49772B (sr) 1997-03-24 1998-03-20 Farmaceutske kompozicije

Country Status (40)

Country Link
US (1) US6004968A (sr)
EP (1) EP0969815B1 (sr)
JP (1) JP3264937B2 (sr)
KR (1) KR100484695B1 (sr)
CN (1) CN1191061C (sr)
AP (1) AP1141A (sr)
AR (1) AR011697A1 (sr)
AT (1) ATE295150T1 (sr)
AU (1) AU728461B2 (sr)
BG (1) BG64690B1 (sr)
BR (1) BR9808060B1 (sr)
CA (1) CA2286126C (sr)
CO (1) CO4980849A1 (sr)
CY (1) CY2569B1 (sr)
CZ (1) CZ298008B6 (sr)
DE (1) DE69830154T2 (sr)
EA (1) EA001990B1 (sr)
EE (1) EE03996B1 (sr)
ES (1) ES2239802T3 (sr)
HK (1) HK1022853A1 (sr)
HN (1) HN1998000045A (sr)
HR (1) HRP980154B1 (sr)
HU (1) HU225600B1 (sr)
ID (1) ID29294A (sr)
IL (1) IL131917A0 (sr)
IS (1) IS2515B (sr)
MY (1) MY116242A (sr)
NO (1) NO326719B1 (sr)
NZ (1) NZ337798A (sr)
PA (1) PA8449301A1 (sr)
PE (1) PE61699A1 (sr)
PL (1) PL190505B1 (sr)
PT (1) PT969815E (sr)
RS (1) RS49772B (sr)
SI (1) SI0969815T1 (sr)
SK (1) SK283417B6 (sr)
SV (1) SV1998000040A (sr)
TW (1) TW536403B (sr)
UY (1) UY24930A1 (sr)
WO (1) WO1998042321A2 (sr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ333099A (en) 1996-06-25 2000-06-23 Glaxo Group Ltd synergistic combinations comprising 141W94, zidovudine and 3TC for use in the treatment of HIV
US6018044A (en) * 1998-01-02 2000-01-25 Roche Vitamins Inc. Light screening compositions
US6432966B2 (en) * 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
JP2003039582A (ja) * 2001-07-19 2003-02-13 Three M Innovative Properties Co 湿潤防滑性シート及び湿潤防滑構造体
US6855346B2 (en) * 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
TWI275392B (en) * 2002-04-08 2007-03-11 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
WO2004075913A1 (ja) 2003-02-28 2004-09-10 Chugai Seiyaku Kabushiki Kaisha タンパク質含有安定化製剤
US20040228804A1 (en) * 2003-05-16 2004-11-18 Jones Alonzo H. Nasal administration of xylitol to a non-human mammal
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
WO2009092002A1 (en) * 2008-01-17 2009-07-23 Duquesne University Of The Holy Spirit Antiretroviral drug formulations for treatment of children exposed to hiv/aids
RU2587782C1 (ru) * 2015-01-19 2016-06-20 Общество с ограниченной ответственностью "Трейдсервис" Стабильная фармацевтическая композиция ламивудина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
AP1141A (en) 2003-01-29
EE03996B1 (et) 2003-04-15
EP0969815B1 (en) 2005-05-11
HUP0002982A3 (en) 2001-12-28
CZ340399A3 (cs) 2000-04-12
IS2515B (is) 2009-06-15
HN1998000045A (es) 1999-03-19
NZ337798A (en) 2001-03-30
HRP980154B1 (en) 2002-06-30
EP0969815A2 (en) 2000-01-12
IL131917A (en) 2001-01-11
HK1022853A1 (en) 2000-08-25
HU225600B1 (en) 2007-05-02
UY24930A1 (es) 2000-10-31
KR100484695B1 (ko) 2005-04-22
JP2001501974A (ja) 2001-02-13
SI0969815T1 (sr) 2005-08-31
WO1998042321A2 (en) 1998-10-01
TW536403B (en) 2003-06-11
CN1191061C (zh) 2005-03-02
CO4980849A1 (es) 2000-11-27
BR9808060B1 (pt) 2009-05-05
NO994619D0 (no) 1999-09-23
PL190505B1 (pl) 2005-12-30
CA2286126C (en) 2003-08-12
JP3264937B2 (ja) 2002-03-11
BR9808060A (pt) 2000-03-08
ATE295150T1 (de) 2005-05-15
BG64690B1 (bg) 2005-12-30
US6004968A (en) 1999-12-21
AU7208498A (en) 1998-10-20
MY116242A (en) 2003-12-31
CY2569B1 (en) 2008-07-02
HRP980154A2 (en) 1998-12-31
NO994619L (no) 1999-11-23
EA199900757A1 (ru) 2000-08-28
WO1998042321A3 (en) 1999-01-07
CN1255849A (zh) 2000-06-07
IS5184A (is) 1999-09-17
EA001990B1 (ru) 2001-10-22
DE69830154D1 (de) 2005-06-16
BG103818A (en) 2000-06-30
DE69830154T2 (de) 2005-10-13
ES2239802T3 (es) 2005-10-01
PA8449301A1 (es) 2000-05-24
CA2286126A1 (en) 1998-10-01
AR011697A1 (es) 2000-08-30
IL131917A0 (en) 2001-03-19
HUP0002982A2 (hu) 2001-01-29
PL336038A1 (en) 2000-06-05
SV1998000040A (es) 1999-03-16
PE61699A1 (es) 1999-07-08
YU47799A (sh) 2002-06-19
CZ298008B6 (cs) 2007-05-23
EE9900440A (et) 2000-04-17
ID29294A (id) 2001-08-16
KR20010005624A (ko) 2001-01-15
AU728461B2 (en) 2001-01-11
AP9901657A0 (en) 1999-09-30
SK129999A3 (en) 2000-07-11
SK283417B6 (sk) 2003-07-01
PT969815E (pt) 2005-07-29
NO326719B1 (no) 2009-02-02

Similar Documents

Publication Publication Date Title
IS4706A (is) Lyfjasamsetningar
IS1947B (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
FI955144A0 (fi) Päällystetyt farmaseuttiset koostumukset
NO20004345D0 (no) Farmasøytisk sammensetning
ZA967034B (en) Pharmaceutical compositions.
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
BR9610153A (pt) Formulações farmacêuticas
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
DZ2026A1 (fr) Compositions vaccinantes.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
IS1846B (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
BR9611367A (pt) Formulação farmacêutic liofilizada estável
RS49633B (sr) Farmaceutske formulacije koje sadrže vorikonazol
ID18352A (id) Komposisi-komposisi farmasi
RS49723B (sr) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
MX210800B (es) Mezclas insecticidas sinergicas.
RS49772B (sr) Farmaceutske kompozicije
DE4493718T1 (de) Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon
FR2698268B1 (fr) Composition photoprotectrice administrée par voie orale.
DE69614407D1 (de) Pharmazeutische zusammensetzungen
DZ1576A1 (fr) Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione.
PT941100E (pt) Composicoes farmaceuticas
FI973280A0 (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FR2779429B1 (fr) Derives d'oxindole, leurs preparations et leurs applications en therapeutique